{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:49:23Z","timestamp":1782506963172,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.celrep.2026.117307","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T21:23:32Z","timestamp":1777065812000},"page":"117307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Conjugated pneumococcal vaccination yields broadly functional, mucosal-directed responses detectable up to at least 42 months in older adults"],"prefix":"10.1016","volume":"45","author":[{"given":"Qixin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate S.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadar","family":"Malca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay R.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Vojicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford D.","family":"Gessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8866-3532","authenticated-orcid":false,"given":"Ryan P.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.117307_bib1","first-page":"1102","article-title":"Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23)","volume":"59","year":"2010","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.celrep.2026.117307_bib2","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","year":"2012","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.celrep.2026.117307_bib3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.15585\/mmwr.mm6846a5","article-title":"Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged \u226565 Years: Updated Recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Matanock","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.celrep.2026.117307_bib4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.15585\/mmwr.mm7336a3","article-title":"Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024","volume":"73","author":"Kobayashi","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.celrep.2026.117307_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.mm7401a1","article-title":"Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged \u226550 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024","volume":"74","author":"Kobayashi","year":"2025","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.celrep.2026.117307_bib6","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1016\/j.vaccine.2012.09.019","article-title":"Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales","volume":"30","author":"Andrews","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2026.117307_bib7","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2015.07.059","article-title":"Long-term impact of pneumococcal polysaccharide vaccination on nasopharyngeal carriage in children previously vaccinated with various pneumococcal conjugate vaccine regimes","volume":"33","author":"Boelsen","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2026.117307_bib8","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.vaccine.2016.02.023","article-title":"Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials","volume":"34","author":"Diao","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2026.117307_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.arbres.2022.12.015","article-title":"Pneumococcal Vaccination in Adults: What Can We Learn From Observational Studies That Evaluated PCV13 and PPV23 Effectiveness in the Same Population?","volume":"59","author":"Dunne","year":"2023","journal-title":"Arch. Bronconeumol."},{"key":"10.1016\/j.celrep.2026.117307_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12050732","article-title":"Systematic Review and Meta-Analysis of the Efficacy and Effectiveness of Pneumococcal Vaccines in Adults","volume":"12","author":"Farrar","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.celrep.2026.117307_bib11","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1093\/clinids\/3.Supplement_1.S119","article-title":"Efficacy of pneumococcal polysaccharide vaccine in preventing acute otitis media in infants in Huntsville, Alabama","volume":"3","author":"Sloyer","year":"1981","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.celrep.2026.117307_bib12","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/cid\/ciy312","article-title":"Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design","volume":"67","author":"McLaughlin","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.celrep.2026.117307_bib13","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117307_bib14","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/cid\/ciab1051","article-title":"Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Medically Attended Lower Respiratory Tract Infection and Pneumonia Among Older Adults","volume":"75","author":"Lewnard","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.celrep.2026.117307_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.1111","article-title":"Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate Vaccine","volume":"5","author":"Hsiao","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.celrep.2026.117307_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jamainternmed.2022.5472","article-title":"Association of Pneumococcal Conjugate Vaccine Use With Hospitalized Pneumonia in Medicare Beneficiaries 65 Years or Older With and Without Medical Conditions, 2014 to 2017","volume":"183","author":"Kobayashi","year":"2023","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.celrep.2026.117307_bib17","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jval.2021.12.012","article-title":"Effectiveness of Pneumococcal Vaccines on Otitis Media in Children: A Systematic Review","volume":"25","author":"Marra","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.celrep.2026.117307_bib18","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/jis212","article-title":"Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells","volume":"205","author":"Clutterbuck","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.celrep.2026.117307_bib19","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180238","article-title":"Structural and immunological characterization of E. coli derived recombinant CRM(197) protein used as carrier in conjugate vaccines","volume":"38","author":"Mishra","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.celrep.2026.117307_bib20","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.vaccine.2019.12.023","article-title":"Peripheral CD4 T follicular cells induced by a conjugated pneumococcal vaccine correlate with enhanced opsonophagocytic antibody responses in younger individuals","volume":"38","author":"Sterrett","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2026.117307_bib21","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41590-023-01717-5","article-title":"Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults","volume":"25","author":"Ravichandran","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117307_bib22","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1016\/j.vaccine.2013.04.085","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2026.117307_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03036-23","article-title":"Understanding Fc function for rational vaccine design against pathogens","volume":"15","author":"Bowman","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2026.117307_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110174","article-title":"Compartment-specific antibody correlates of protection to SARS-CoV-2 Omicron in macaques","volume":"27","author":"Tong","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.celrep.2026.117307_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm3151","article-title":"Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection","volume":"14","author":"Dias","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2026.117307_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abj2901","article-title":"Early cross-coronavirus reactive signatures of humoral immunity against COVID-19","volume":"6","author":"Kaplonek","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2026.117307_bib27","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/infdis\/jiad115","article-title":"Accumulation of Neutrophil Phagocytic Antibody Features Tracks With Naturally Acquired Immunity Against Malaria in Children","volume":"228","author":"Nziza","year":"2023","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.celrep.2026.117307_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112402","article-title":"Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates","volume":"42","author":"Gunn","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117307_bib29","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.immuni.2021.03.009","article-title":"A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus","volume":"54","author":"Gunn","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117307_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg6128","article-title":"Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects","volume":"13","author":"Meyer","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2026.117307_bib31","article-title":"Humoral correlates of protection against","volume":"27","author":"Irvine","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.celrep.2026.117307_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.856906","article-title":"Defining Discriminatory Antibody Fingerprints in Active and Latent Tuberculosis","volume":"13","author":"Nziza","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2026.117307_bib33","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s41590-021-01066-1","article-title":"Robust IgM responses following intravenous vaccination with Bacille Calmette-Gu\u00e9rin associate with prevention of Mycobacterium tuberculosis infection in macaques","volume":"22","author":"Irvine","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117307_bib34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/imr.12503","article-title":"Systems serology for evaluation of HIV vaccine trials","volume":"275","author":"Ackerman","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.celrep.2026.117307_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005315","article-title":"Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control","volume":"12","author":"Ackerman","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2026.117307_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adu7646","article-title":"Adenovirus and mRNA vaccines as well as mucosal boosting improve protective efficacy against influenza virus challenge in macaques","volume":"17","author":"Jacob-Dolan","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2026.117307_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ady2282","article-title":"An intramuscular prime and mucosal boost vaccine regimen protects against lethal clade 2.3.4.4b H5N1 challenge in cynomolgus macaques","volume":"17","author":"Lasrado","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2026.117307_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41541-023-00791-y","article-title":"Boosting with adjuvanted SCB-2019 elicits superior Fc\u03b3-receptor engagement driven by IgG3 to SARS-CoV-2 spike","volume":"9","author":"Jung","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.celrep.2026.117307_bib39","article-title":"Antibodies as key mediators of protection against","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2026.117307_bib40","article-title":"Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concern","volume":"14","author":"McNamara","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2026.117307_bib41","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41564-023-01359-1","article-title":"Fc-\u03b3R-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2","volume":"8","author":"Mackin","year":"2023","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2026.117307_bib43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/(SICI)1099-0496(199609)22:3<167::AID-PPUL5>3.0.CO;2-M","article-title":"Post-immunization pneumococcal antibody titers and IgG subclasses","volume":"22","author":"Sorensen","year":"1996","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.celrep.2026.117307_bib44","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1128\/IAI.67.9.4935-4938.1999","article-title":"Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination","volume":"67","author":"Lottenbach","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.celrep.2026.117307_bib45","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1128\/IAI.73.4.2541-2546.2005","article-title":"Antibody against the carboxyl terminus of intimin alpha reduces enteropathogenic Escherichia coli adherence to tissue culture cells and subsequent induction of actin polymerization","volume":"73","author":"Carvalho","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.celrep.2026.117307_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7203a1","article-title":"Pneumococcal Vaccine for Adults Aged \u226519 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023","volume":"72","author":"Kobayashi","year":"2023","journal-title":"MMWR Recomm. Rep. (Morb. Mortal. Wkly. Rep.)"},{"key":"10.1016\/j.celrep.2026.117307_bib47","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-3083.1989.tb01225.x","article-title":"The IgG subclass pattern of complement activation depends on epitope density and antibody and complement concentration","volume":"30","author":"Garred","year":"1989","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.celrep.2026.117307_bib48","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102787118","article-title":"C1q binding to surface-bound IgG is stabilized by C1r(2)s(2) proteases","volume":"118","author":"Zwarthoff","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117307_bib49","article-title":"The Effects of Secretory IgA in the Mucosal Immune System","volume":"2020","author":"Li","year":"2020","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.celrep.2026.117307_bib50","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3201\/eid2801.210956","article-title":"Streptococcus pneumoniae Serotypes Associated with Death, South Africa, 2012-2018","volume":"28","author":"M\u00fcller","year":"2022","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.celrep.2026.117307_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113292","article-title":"Beta-spike-containing boosters induce robust and functional antibody responses to SARS-CoV-2 in macaques primed with distinct vaccines","volume":"42","author":"Deng","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117307_bib52","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1172\/JCI129520","article-title":"Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination","volume":"130","author":"Boudreau","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celrep.2026.117307_bib53","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41564-024-01678-x","article-title":"Age and sex influence antibody profiles associated with tuberculosis progression","volume":"9","author":"Davies","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2026.117307_bib55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jim.2017.01.010","article-title":"Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles","volume":"443","author":"Brown","year":"2017","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.celrep.2026.117307_bib56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jim.2012.09.007","article-title":"High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples","volume":"386","author":"Brown","year":"2012","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.celrep.2026.117307_bib57","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cell.2018.07.033","article-title":"Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection","volume":"174","author":"Saphire","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117307_bib58","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s41590-018-0233-9","article-title":"Antibody-mediated protection against Ebola virus","volume":"19","author":"Saphire","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117307_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2019.07.002","article-title":"A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation","volume":"473","author":"Fischinger","year":"2019","journal-title":"J. Immunol. Methods"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726003852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726003852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:26:18Z","timestamp":1782505578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726003852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2211124726003852"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117307","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conjugated pneumococcal vaccination yields broadly functional, mucosal-directed responses detectable up to at least 42 months in older adults","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117307"}}